Advertisement

Hospital pharmacy news, drug costs and specialty pharmacy trends

Becker’s reports on drug prices, shortages and the specialty pharmacy programs health systems are building. Coverage extends to 340B policy, pharmacy staffing and the distribution models.



More in Pharmacy

The specialty pharmacy operated by Allentown, Pa.-based Lehigh Valley Health Network, under Philadelphia-based Jefferson Health, filed a lawsuit Nov. 10 against Highmark regarding the ability to dispense drugs. The complaint, filed in a state court, alleged that Highmark is blocking…

Humana has launched a cancer care model aimed at easing the prior authorization process for oncology providers.  The model was developed in partnership with the American Oncology Network and specialty care management company Evolent, according to a Nov. 10 news…

Caplyta, a Johnson & Johnson drug, met its primary and key secondary endpoints in a second pivotal phase 3 trial evaluating it for manic episodes in adults with bipolar I disorder. Study 452 found that Caplyta significantly reduced manic symptoms…

Beam Therapeutics’ investigational gene-edited therapy for sickle cell disease met its primary efficacy endpoint in a Phase 1/2 clinical trial, bringing the company closer to a planned FDA submission. The biotech said Nov. 10 that its BEACON study of ristoglogene…

MaxCyte has entered an agreement to acquire Akron Bio for $151.8 million, a deal expected to nearly double its revenue base and expand its cell therapy manufacturing business. The transaction, announced Nov. 10, is expected to close before the end…

The FDA has approved Bayer’s Sunharbo (asundexian), the first factor XIa inhibitor, after a phase 3 trial found the drug reduced the risk of ischemic stroke by 26% compared with placebo over a median treatment period of 14.2 months. The…

Democrats won majorities in both the House and Senate in the Nov. 3 midterms, giving the party control of Congress when the new session begins Jan. 3. Until then, Republicans retain control of both chambers. President Donald Trump retains veto…

Advertisement
Advertisement
Advertisement